Mateusz Opyrchal

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Venues

Cancers

NPJ breast cancer

Nature genetics

Clinical cancer research : an official journal of the American Association for Cancer Research

Washington University in Saint Louis

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Washington University in Saint Louis Sep 16 2019

United States

Associate Professor :: Medical Oncology

Roswell Park Cancer Institute - Aug 12 2019

United States

Assistant Professor :: Medicine

Publications

Rylee Ann Poole, Qingfei Wang, Alo Ray, Kazuaki Takabe, Mateusz Opyrchal, Eriko Katsuta
Increased PIEZO1 Expression Is Associated with Worse Clinical Outcomes in Hormone-Receptor-Negative Breast Cancer Patients. Cancers 16 (4) (2024)
Filip Janku, Grace M Choong, Mateusz Opyrchal, Afshin Dowlati, Cinta Hierro, Jordi Rodon, Andreas Wicki, Martin D Forster, Sarah P Blagden, Jun Yin, Joel M Reid, Helene Muller, Natasa Cmiljanovic, Vladimir Cmiljanovic, Alex A Adjei
A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors. Cancers 16 (6) (2024)
Rylee Ann Poole, Qingfei Wang, Alo Ray, Kazuaki Takabe, Mateusz Opyrchal, Eriko Katsuta
Increased PIEZO1 Expression Is Associated with Worse Clinical Outcomes in Hormone-Receptor-Negative Breast Cancer Patients. Cancers 16 (4) (2024)
Ateeq M Khaliq, Meenakshi Rajamohan, Omer Saeed, Kimia Mansouri, Asif Adil, Chi Zhang, Anita Turk, Julienne L Carstens, Michael House, Sikander Hayat, Ganji P Nagaraju, Sam G Pappas, Y Alan Wang, Nicholas J Zyromski, Mateusz Opyrchal, Kelvin P Lee, Heather M O'Hagan, Bassel El Rayes, Ashiq Masood
Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneity. Nature genetics (2024)
Filip Janku, Grace M Choong, Mateusz Opyrchal, Afshin Dowlati, Cinta Hierro, Jordi Rodon, Andreas Wicki, Martin D Forster, Sarah P Blagden, Jun Yin, Joel M Reid, Helene Muller, Natasa Cmiljanovic, Vladimir Cmiljanovic, Alex A Adjei
A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors. Cancers 16 (6) (2024)
Foluso O Ademuyiwa, Donald W Northfelt, Tracey O'Connor, Ellis G Levine, Jingqin R Luo, Yu Tao, Jeremy Hoog, Marie L Laury, Tracy Summa, Trish Hammerschmidt, Zhanfang Guo, Ashley Frith, Katherine Weilbaecher, Mateusz Opyrchal, Rebecca Aft, Katherine Clifton, Rama Suresh, Nusayba Bagegni, Ian S Hagemann, Michael D Iglesia, Cynthia X Ma
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN). NPJ breast cancer 9 (1) (2023)
Whitney L Hensing, Lorenzo Gerratana, Katherine K Clifton, Arielle J Medford, Marko Velimirovic, Ami N Shah, Paolo D'Amico, Giancarlo Feliciello, Qiang Zhang, Charles S Dai, Elyssa N Denault, Nusayba A Bagegni, Mateusz Opyrchal, Foluso O Ademuyiwa, Ron Bose, Amir Behdad, Cynthia X Ma, Aditya Bardia, Massimo Cristofanilli, Andrew A Davis
Genetic alterations detected by circulating tumor DNA in HER2-low metastatic breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Foluso O Ademuyiwa, Donald W Northfelt, Tracey O'Connor, Ellis G Levine, Jingqin R Luo, Yu Tao, Jeremy Hoog, Marie L Laury, Tracy Summa, Trish Hammerschmidt, Zhanfang Guo, Ashley Frith, Katherine Weilbaecher, Mateusz Opyrchal, Rebecca Aft, Katherine Clifton, Rama Suresh, Nusayba Bagegni, Ian S Hagemann, Michael D Iglesia, Cynthia X Ma
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN). NPJ breast cancer 9 (1) (2023)
Foluso O Ademuyiwa, Donald W Northfelt, Tracey O'Connor, Ellis G Levine, Jingqin R Luo, Yu Tao, Jeremy Hoog, Marie L Laury, Tracy Summa, Trish Hammerschmidt, Zhanfang Guo, Ashley Frith, Katherine Weilbaecher, Mateusz Opyrchal, Rebecca Aft, Katherine Clifton, Rama Suresh, Nusayba Bagegni, Ian S Hagemann, Michael D Iglesia, Cynthia X Ma
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN). NPJ breast cancer 9 (1) (2023)
Eriko Katsuta, Kazuaki Takabe, Marija Vujcic, Philip A Gottlieb, Tao Dai, Arnaldo Mercado-Perez, Arthur Beyder, Qingfei Wang, Mateusz Opyrchal
Mechano-Sensing Channel PIEZO2 Enhances Invasive Phenotype in Triple-Negative Breast Cancer. International journal of molecular sciences 23 (17) (2022)
Ravi Kumar Gupta, Arya Mariam Roy, Ashish Gupta, Kazuaki Takabe, Ajay Dhakal, Mateusz Opyrchal, Pawel Kalinski, Shipra Gandhi
Systemic Therapy De-Escalation in Early-Stage Triple-Negative Breast Cancer: Dawn of a New Era? Cancers 14 (8) (2022)
Ajay Dhakal, Roby Antony Thomas, Ellis G Levine, Adam Brufsky, Kazuaki Takabe, Matthew G Hanna, Kristopher Attwood, Austin Miller, Thaer Khoury, Amy P Early, Saif Soniwala, Tracy O'Connor, Mateusz Opyrchal
Outcome of Everolimus-Based Therapy in Hormone-Receptor-Positive Metastatic Breast Cancer Patients After Progression on Palbociclib. Breast cancer : basic and clinical research 14 (2020)
Usha Malhotra, Sarbajit Mukherjee, Christos Fountzilas, Patrick Boland, Austin Miller, Santosh Patnaik, Kristopher Attwood, Sai Yendamuri, Araba Adjei, Eric Kannisto, Mateusz Opyrchal, Peter Bushunow, Peter Loud, Renuka Iyer, Nikhil Khushalani
Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates. Molecular cancer therapeutics 19 (1) (2019)

Mateusz Opyrchal.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mateusz Opyrchal